HCP
58
-8
PM
64
-4
FOX
39
-3
DTE
58
-7
BRK.B
45
-9
MDT
56
-4
MPC
36
-16
PSA
60
-3
HOG
38
2
NVDA
44
4
TSN
44
-2
CMCSA
50
5
KEY
51
-2
TGNA
34
-6
BAX
35
5
HRL
32
3
URI
48
-2
JBHT
45
-4
SYF
62
-2
STI
19
2
HCP
58
-8
PM
64
-4
FOX
39
-3
DTE
58
-7
BRK.B
45
-9
MDT
56
-4
MPC
36
-16
PSA
60
-3
HOG
38
2
NVDA
44
4
TSN
44
-2
CMCSA
50
5
KEY
51
-2
TGNA
34
-6
BAX
35
5
HRL
32
3
URI
48
-2
JBHT
45
-4
SYF
62
-2
STI
19
2
Financhill
Back

Beam Therapeutics Stock Predictions

Potential crash warning signs flashing again on my charts

Here's my #1 indicator to try out now.
Sell
18

BEAM
Beam Therapeutics

Last Price:
23.25
Seasonality Move:
23.47%

7 Day Trial

ALL ACCESS PASS

$ 7

The Biggest Financial Event of 2024?

Click here to find out.

Beam Therapeutics Stock Forecast

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 58.6% based on the past 4 years of stock performance.
  • Beam Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Beam Therapeutics Stock Undervalued?
    The current Beam Therapeutics [BEAM] share price is $23.30. The Score for BEAM is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • BEAM is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Beam Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Beam Therapeutics has on average historically risen by 58.6% based on the past 4 years of stock performance.

Beam Therapeutics Stock Rating

Sell
18
Beam Therapeutics (BEAM) is a Sell

Is Beam Therapeutics overpriced?

  • Beam Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Beam Therapeutics Stock Price History

Is BEAM stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BEAM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com

52-Week Data

52-Week High:
49.50
52-Week Low:
16.95

Prediction Charts

Market Cap:
1.92B
Price in USD:
23.30
Volume:
385.92K
Beta:
1.78

Technical Analysis

SMA50:
26.04
SMA100:
24.88
SMA200:
27.52
52-Wk Change:
-5.52%

Stock Predictions

  • Is Beam Therapeutics stock public?
    Yes, Beam Therapeutics is a publicly traded company.
  • What is the Beam Therapeutics stock quote today?
    The Beam Therapeutics stock price is 23.30 USD today.
  • How to buy Beam Therapeutics stock online?
    You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-19 24.51 25.00 25.70 24.40
Aug-20 25.00 24.53 25.41 24.42
Aug-21 24.70 25.49 25.73 24.43
Aug-22 25.65 24.55 25.65 24.45
Aug-23 24.87 26.81 26.86 24.28
Aug-26 27.17 27.13 27.40 26.45
Aug-27 26.91 26.29 27.12 25.26
Aug-28 26.03 26.05 26.30 25.49
Aug-29 26.39 26.84 27.71 26.17
Aug-30 27.04 26.68 27.26 26.16
Sep-3 26.34 24.40 27.17 24.37
Sep-4 24.32 24.08 24.84 23.85
Sep-5 24.22 24.19 24.76 23.91
Sep-6 24.29 23.30 24.58 23.07

Beam Therapeutics Earnings

Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Beam Therapeutics Forecast Revenue Growth

Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.46 per share, and an increase next year of $0.07 per share.

* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.